Uncategorized

Prenatal Testing & Newborn Screening Market Forecast: What to Expect by 2029

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Prenatal Testing & Newborn Screening Market Between 2025 And 2029?

The prenatal testing & newborn screening market has experienced substantial growth in recent times. Projections indicate its expansion from $6.24 billion in 2024 to $6.98 billion by 2025, driven by a compound annual growth rate (CAGR) of 11.8%. Historically, this growth can be ascribed to progress in genetic testing, a rise in maternal age, enhanced awareness and education, and supportive healthcare policy and regulations.

The prenatal testing & newborn screening market size is poised for considerable growth in the upcoming years. Its size is projected to expand to $10.99 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 12.0%. This expansion during the forecast period stems from factors such as genetic counseling, technological advancements, point-of-care testing, telehealth, and remote monitoring. Key trends observed in the forecast period involve non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), telemedicine consultations, maternal blood testing, along with screening for hemoglobinopathies and sickle cell.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Prenatal Testing & Newborn Screening Industry?

The widespread occurrence of genetic conditions in infants has significantly driven the expansion of the prenatal testing & newborn screening market. The World Health Organization defines genetic disease to include ailments such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington’s disease. Among these, sickle cell anemia is a genetic disorder affecting millions worldwide, observed to be especially prevalent in individuals with ancestry from Africa, America, Cuba, Central America, Saudi Arabia, and India. For example, a study in February 2023, conducted at Rady Children’s Hospital by the US-based Rady Children’s Institute for Genomic Medicine, revealed that 41% of infant deaths were caused by single-locus (Mendelian) genetic diseases. This high incidence of genetic diseases in infants has consequently fueled the expansion and demand within the prenatal testing and newborn screening market.

How Is The Prenatal Testing & Newborn Screening Market Classified Into Different Segments?

The prenatal testing & newborn screeningmarket covered in this report is segmented –

1) By Diagnostic Type: Non-Invasive; Invasive

2) By Technology: Screening Technology; Diagnostic Technology

3) By End user: Hospitals; Diagnostic centers

Subsegments:

1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing); Ultrasound; Maternal Serum Screening

2) By Invasive: Amniocentesis; Chorionic Villus Sampling (CVS); Cordocentesis

What Long-Term Trends Will Shape The Future Growth Of The Prenatal Testing & Newborn Screening Industry?

Key companies within the prenatal testing & newborn screening market are concentrating on launching innovative initiatives that leverage rapid Whole Genome Sequencing (rWGS) technology. The objective is to swiftly and accurately detect genetic disorders in newborns, thereby enabling early diagnosis and intervention to improve health outcomes. Rapid Whole Genome Sequencing (rWGS) technology represents an advanced genomic method designed to rapidly sequence an individual’s entire genome. Unlike traditional genetic testing approaches, which focus on specific genes or regions, rWGS captures all DNA within an individual’s genome to identify genetic variants associated with diseases or disorders. For example, in June 2022, Rady Children’s Institute for Genomic Medicine, a US-based firm, introduced BeginNGS, a pioneering program. This initiative is designed to identify and diagnose approximately 400 genetic disorders with known treatment options before any symptoms appear. BeginNGS is actively optimizing genomic sequencing processes, with future plans to expand its testing capabilities to cover around 1,000 disorders. The ultimate aspiration is to enable screening for 3.7 million newborns annually, establishing it as a standard practice in hospitals across the nation.

Who Are The Top Performing Companies In The Prenatal Testing & Newborn Screening Market In Recent Years?

Major companies operating in the prenatal testing & newborn screening market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Natera Inc., Invitae Corporation, Centogene AG, Cradle Genomics Inc., Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc., Progenity Inc., Ravgen Inc., Strand Life Sciences Pvt. Ltd., Eurofins Scientific, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., General Electric Company, Siemens Healthineers AG, BGI Group, QIAGEN N.V., Veracyte Inc., NIPD Genetics, Novacyt UK, Ariosa Diagnostics Inc., Verinata Health Inc., Counsyl a Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid a Danaher Company, Guardant Health Inc., Genetron Health (Beijing) Co. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Prenatal Testing & Newborn Screening Market?

North America was the largest region in the prenatal testing & newborn screening market in 2024. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Prenatal Testing & Newborn Screening Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp

Browse Through More Reports Similar to the Global Prenatal Testing & Newborn Screening Market 2025, By The Business Research Company

Non Invasive Prenatal Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

Testing Inspection And Certification Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/testing-inspection-and-certification-global-market-report

Genetic Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795